Pet Diabetes Management Market By Product Type (Insulin Delivery Devices { Insulin Pens and Insulin Syringes, Glucose Monitoring Devices: Diagnostic kits, Glucometers} Medications {Oral drugs, Injections, and Others}), By Pet Type (Dogs, Cats, and Others), By Distribution Channel (Online Pharmacies, Pet Specialty Stores, Veterinary Clinics & Hospitals and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Pet Diabetes Management market accounted for USD 2.48 Billion in 2024 and is expected to reach USD 6.15 Billion by 2035, growing at a CAGR of around 8.5% between 2025 and 2035. The pet diabetes management market focuses on products and services designed for the treatment of diabetes in pets, especially dogs and cats. It spans insulin therapies, monitoring devices, special diets, and educational resources for pet owners. There are also emerging educational platforms and apps that would enable tracking and management of pets through various apps. The increasing rise in cases such as obesity turns out to make this a more robust market with increasing awareness and demand for better veterinary care. Glucose monitors and mobile apps are two examples of technologies that further the possibilities for management options. The market is generally focused on improving the quality of life for diabetic pets as well as reducing the burden from those pets on their owners.

Report Scope:

Market Dynamics

Growing Awareness of Nutritional Needs Fuels Demand for Diabetes-Friendly Pet Diets

The key drivers for the Pet Diabetes Management market include the rising demand for specialized diets for pets and diabetes-friendly food options. Since pet owners are well aware of the nutritional needs of their pets, awareness related to the important role diet plays in managing conditions such as diabetes is gradually gaining recognition. This awareness is facilitated through statistics provided by the Association for Pet Obesity Prevention(APOP) which showed that approximately 60% of the cats and 56% of the dogs in the U.S. are categorized overweight or obese, thus leading to diabetes.

Therefore, responding pet food manufacturers now offer diets tailored to meet the needs of pets so as to regulate blood sugar and overall health. Such specialized diets are more likely to have a low carbohydrate content and higher fiber. This will serve diabetic pets especially, hence driving product innovation as well as market growth. It reflects not only the changing nature of pet care but also elaborates on almost a proactive approach in terms of chronic health issues through diet.

Financial Constraints as a Major Barrier to Effective Pet Diabetes Management

The cost of caring for a pet with diabetes can be a significant barrier for many owners, making it a major drawback in the Pet Diabetes Management market. Owners may face recurring expenses for insulin treatment, special diet, and monitoring equipment. According to the American Veterinary Medical Association (AVMA) report, cost appeared to be the largest barrier to veterinary care across all demographic groups, with 49.6% of participants indicating cost as a challenge.

This financial pressure can delay diagnosis and treatment, leading to worsened pet health and increased overall costs. Because of these high management costs, some owners may seek more affordable alternatives or even discontinue care altogether. This creates a demand for alternative solutions that are more affordable in the market. Addressing these cost barriers is crucial for improving the health of diabetic pets.

Transforming Pet Care with Apps for Tracking Health and Medications in Diabetic Pets

The opportunity in the Pet Diabetes Management market can be found in apps that are specifically designed to monitor pet health, prescription medications, and specialized diets relating to diabetes. It can facilitate easy monitoring of glucose levels in pets, remind the owner to administer medications and control special diets. As more and more pet owners search for simpler solutions at an arm's length through technology, it keeps increasing the users' engagement with the treatment plan.

More features like monitoring of progress and education resources can engage owners with active participation in healthy upkeep, with decision making. Above all, the apps also facilitate a type of community when they are used, in a world that is increasingly digital for health solutions. Overall, they will lead to better health outcomes for diabetic pets as well as better customer loyalty.

Industry Experts Opinion

“We are excited to bring Senvelgo oral solution to the market because it will really support cat owners and their diabetic cats to continue to enjoy a normal life, despite this chronic disease.”

•  Nikki Milne, business head of pet at Boehringer Ingelheim

Segment Analysis

Based on the product type, the Pet Diabetes Management market has been classified into Insulin Delivery Devices, Glucose Monitoring Devices, Medications, and Others. The market is further segmented by Insulin Delivery Devices product type into Insulin pens and Insulin Syringes. Based on the Glucose Monitoring Devices the market is further classified as Diagnostic kits and Glucometers. Based on the Medications the market is further classified as Oral drugs and Injections. The Insulin Delivery Devices type of required delivery devices, especially the insulin pen, has fully occupied the leader's edge in diabetes management due to its convenience and user-friendliness. It allows greater precision in insulin dosing, and portability helps invent a patient-friendly administration mechanism that promotes treatment adherence. Smarter devices have progressed due to advanced technology. The high prevalence of diabetes means a great demand in the developing world for pragmatic insulin delivery methods.

Based on the pet type, the market of Pet Diabetes Management has been classified into dogs, cats, and others. The Pet Diabetes Management market mainly focuses on dogs due to their higher incidence of diabetes and the fact that more people own dogs as pets. Dog owners typically spend more on veterinary care and diabetes management products, such as insulin and monitoring devices. While cats also experience diabetes, the market for managing their condition is usually smaller.

Regional Analysis

North America is the leading industry in the Pet Diabetes Management Market mainly in the United States, given the high rate of diabetes among pets and the significant investment made into veterinary care. The rising awareness amongst pet owners about pet health and regularly taking their pets for check-ups has made them seek treatments that include insulin, glucose monitoring devices, and special diets. The growing number of pet obesity issues a huge risk factor for diabetes-have led the owners to look for preventive and managerial measures. Additionally, the introduction of many innovative products including continuous glucose monitoring systems is sustaining the market growth within this region.

The Pet Diabetes Management Market in Europe is also slated to grow exponentially, primarily driven by the burgeoning pet ownership rates and rising awareness of health issues associated with pets, particularly for some of countries like the UK and Germany, among others, leading in the adoption of diabetes management solutions. The market is further promoted by the emerging trend concerning pet insurance, convincing owners to seek better care for their pets. Finally, improvements in veterinary medicine and specialization in pet foods for diabetic animals have also opened up opportunities for diabetes management in pets. Now that pet owners are increasingly becoming aware of diabetes and its management, the demand for efficient solutions is anticipated to experience even greater growth in the future, with Europe being poised to become the backbone for this market segment.

Competitive Landscape

The competitive landscape of the Pet Diabetes Management Market is characterized by several key players, such as Zoetis, Merck Animal Health, Elanco, and Bayer Animal Health. These companies are on the frontlines of innovation for diabetes management in pets to further propel market growth. Recently, these include the launch of a new veterinary insulin product designed by Zoetis, whereby this aims to afford better glycemic control over pets.

The preponderant emphasis on research and development has led to the formulation of devices for advanced diabetic monitoring and systems for insulin delivery, enhancing the management of diabetes in pets. As the awareness of pet health rises, these companies are investing heavily in marketing and education to communicate their various offerings to pet owners, thus affording them security within the expanding market.

Pet Diabetes Management Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In August, 2023, Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has approved SENVELGO® (velagliflozin oral solution), a ground-breaking new treatment for cats with diabetes. Cat owners can give their cats SENVELGO®, a once-daily liquid oral solution, straight into their mouths or mixed with a small amount of food.
• In December, 2022, The United States FDA has approved Bexacat, bexagliflozin tablets, to be the first oral treatment for improving glycemic control in non-insulin treated cats suffering from diabetes. This SGLT2 inhibitor is the first of its kind approved in any animal species while carrying a warning to be careful in patient selection because of a risk of potentially serious adverse effects.

Report Coverage:

By Product Type

• Insulin Delivery Devices
  • Insulin pens
  • Insulin Syringes
• Glucose Monitoring Devices
  • Diagnostic kits
  • Glucometers
• Medications
  • Oral drugs
  • Injections
• Others

By Pet Type

• Dogs
• Cats
• Others

By Distribution Channel

• Online Pharmacies
• Pet Specialty Stores
• Veterinary Clinics & Hospitals
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Zoetis
• Merial
• Elanco
• Vetoquinol
• Virbac
• Boehringer Ingelheim
• PetDx
• Diabetes Management Services
• PetSage
• PawTree
• Vet's Best
• Hill's Pet Nutrition
• Royal Canin
• Purina Pro Plan Veterinary Diets
• Chewy, Inc.

Frequently Asked Questions (FAQs)